Department of Radiation Oncology, Rush University Medical Center, Chicago, IL 60612, USA.
Int J Radiat Oncol Biol Phys. 2010 Sep 1;78(1):104-10. doi: 10.1016/j.ijrobp.2009.07.1705. Epub 2009 Dec 11.
For patients with left-sided breast cancers, radiation treatment to the intact breast results in high doses to significant volumes of the heart, increasing the risk of cardiac morbidity, particularly in women with unfavorable cardiac anatomy. We compare helical tomotherapy (TOMO) and inverse planned intensity modulated radiation therapy (IMRT) with three-dimensional conformal radiotherapy using opposed tangents (3D-CRT) for reductions in cardiac volumes receiving high doses.
Fifteen patients with left-sided breast cancers and unfavorable cardiac anatomy, determined by a maximum heart depth (MHD) of >or=1.0 cm within the tangent fields, were planned for TOMO and IMRT with five to seven beam angles, in addition to 3D-CRT. The volumes of heart and left ventricle receiving >or=35 Gy (V35) were compared for the plans, as were the mean doses to the contralateral breast and the volume receiving >or=20 Gy (V20) for the ipsilateral lung.
The mean MHD was 1.7 cm, and a significant correlation was observed between MHD and both heart and left ventricle V35. The V35s for IMRT (0.7%) and TOMO (0.5%) were significantly lower than for 3D-CRT (3.6%). The V20 for IMRT (22%) was significantly higher than for 3D-CRT (15%) or TOMO (18%), but the contralateral breast mean dose for TOMO (2.48 Gy) was significantly higher than for 3D-CRT (0.93 Gy) or IMRT (1.38 Gy).
Both TOMO and IMRT can significantly reduce cardiac doses, with modest increases in dose to other tissues in left-sided breast cancer patients with unfavorable cardiac anatomy.
对于左侧乳腺癌患者,乳房完整放疗会导致心脏受到高剂量照射,从而增加心脏发病风险,尤其是对于心脏解剖结构不佳的患者。我们比较了螺旋断层放疗(TOMO)、逆向调强放疗(IMRT)和三维适形放疗(3D-CRT)在减少心脏高剂量照射体积方面的效果。
15 例左侧乳腺癌且心脏解剖结构不佳的患者(切线野内最大心脏深度(MHD)≥1.0cm),采用 TOMO 和 5-7 个射野的 IMRT 进行计划设计,此外还采用了 3D-CRT。比较了这些计划中心脏和左心室接受>or=35Gy(V35)的体积,以及对侧乳腺的平均剂量和同侧肺接受>or=20Gy(V20)的体积。
平均 MHD 为 1.7cm,MHD 与心脏和左心室 V35 均呈显著相关。IMRT(0.7%)和 TOMO(0.5%)的 V35 明显低于 3D-CRT(3.6%)。IMRT(22%)的 V20 明显高于 3D-CRT(15%)和 TOMO(18%),但 TOMO(2.48Gy)的对侧乳腺平均剂量明显高于 3D-CRT(0.93Gy)和 IMRT(1.38Gy)。
TOMO 和 IMRT 均可显著降低心脏剂量,对于心脏解剖结构不佳的左侧乳腺癌患者,会导致其他组织剂量适度增加。